Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (1,961)

Search Parameters:
Keywords = pulmonary complications

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
18 pages, 641 KB  
Article
Pulmonary Embolism in Hospitalized COVID-19 Patients: Incidence, Clinical Predictors, and Short-Term Outcomes
by Cristiana Adina Avram, Maria-Laura Craciun, Ana-Maria Pah, Stela Iurciuc, Simina Crisan, Cristina Vacarescu, Ioana Cotet, Claudia Raluca Balasa Virzob, Dan Alexandru Surducan and Claudiu Avram
J. Clin. Med. 2026, 15(8), 3117; https://doi.org/10.3390/jcm15083117 - 19 Apr 2026
Abstract
Background/Objectives: Pulmonary embolism (PE) represents a major thrombotic complication in hospitalized patients with coronavirus disease 2019 (COVID-19), yet data on its incidence, clinical predictors, and short-term outcomes in actual cohorts remain heterogeneous. Methods: We conducted a retrospective observational cohort study including [...] Read more.
Background/Objectives: Pulmonary embolism (PE) represents a major thrombotic complication in hospitalized patients with coronavirus disease 2019 (COVID-19), yet data on its incidence, clinical predictors, and short-term outcomes in actual cohorts remain heterogeneous. Methods: We conducted a retrospective observational cohort study including 395 consecutive adults hospitalized with RT-PCR-confirmed COVID-19 at a tertiary infectious diseases center between March 2020 and December 2024. Clinical, laboratory, imaging, and treatment data were extracted from electronic records, and PE was defined by computed tomography pulmonary angiography. Univariable and multivariable logistic regression analyses were used to identify independent predictors of PE in the subset of patients who underwent CTPA (n = 120), in whom PE status was definitively ascertained (47 with PE and 73 without PE). Results: Pulmonary embolism was diagnosed in 47 patients (11.9%). Patients with PE more frequently had prior venous thromboembolism (19.1% vs. 8.3%) and prolonged immobilization (61.7% vs. 23.0%), and were more often admitted to the intensive care unit (12.8% vs. 4.3%) than those without PE. Peak D-dimer levels were almost ten-fold higher in the PE group (median 5322 vs. 529.5 µg/L). In multivariable logistic regression, peak D-dimer was independently associated with PE (per log-unit increase, adjusted OR 3.9, 95% CI 2.1–7.1), and prolonged immobilization conferred a substantially higher risk of PE (adjusted OR 5.1, 95% CI 2.4–10.9). Patients with PE experienced more complex hospital courses and more frequent need for advanced therapies, although in-hospital mortality did not differ significantly between groups. Conclusions: In hospitalized COVID-19 patients, PE is frequent and closely linked to marked D-dimer elevation and acquired in-hospital risk factors, particularly prolonged immobilization. This evidence supports the use of dynamic D-dimer assessment and careful evaluation of immobilization status to improve risk stratification, guide decisions on diagnostic imaging and anticoagulation intensity, and identify patients who may benefit from closer post-discharge cardiovascular follow-up (this hypothesis requires confirmation in future prospective studies). Full article
(This article belongs to the Special Issue Sequelae of COVID-19: Clinical to Prognostic Follow-Up)
Show Figures

Figure 1

10 pages, 1292 KB  
Case Report
Tuberculous Aneurysm of the Thoracic Aorta: A Diagnostic and Therapeutic Challenge in the Modern Era
by Sanja Šarac, Momir Šarac, Rade Milić, Biljana Lazović-Popović and Jelena Vuković
J. Clin. Med. 2026, 15(8), 3104; https://doi.org/10.3390/jcm15083104 - 18 Apr 2026
Viewed by 40
Abstract
Introduction: Tuberculous aneurysm of the thoracic aorta (TBAA) is an extremely rare but potentially fatal manifestation of tuberculosis (TB). Clinical presentation may include hemoptysis in the absence of parenchymal lung abnormalities. Case report: We presented a 62-year-old male with cough, chest pain, [...] Read more.
Introduction: Tuberculous aneurysm of the thoracic aorta (TBAA) is an extremely rare but potentially fatal manifestation of tuberculosis (TB). Clinical presentation may include hemoptysis in the absence of parenchymal lung abnormalities. Case report: We presented a 62-year-old male with cough, chest pain, and minimal hemoptysis. Diagnostic evaluation confirmed an aneurysm of the descending thoracic aorta at a site previously treated with endovascular repair, with no imaging findings suggestive of pulmonary TB. Bronchoscopy revealed blood in the main bronchi without an identifiable endobronchial source. The diagnosis of TB was established by polymerase chain reaction (PCR) testing of bronchial aspirate obtained during bronchoscopy. Emergency surgical intervention was recommended because of an impending aortic rupture, but the patient declined surgery. Standard antituberculous therapy was initiated, and the patient subsequently developed drug-induced liver injury, prompting temporary cessation of treatment. The clinical course was later complicated by the development of an aortoesophageal fistula (AEF), with significant implications for prognosis. Conclusions: Early recognition of TBAA, along with a multidisciplinary approach that integrates advanced diagnostic modalities, timely vascular intervention, and carefully managed antituberculous therapy, is essential to reduce mortality and optimize treatment outcomes. Full article
(This article belongs to the Section Vascular Medicine)
Show Figures

Figure 1

19 pages, 1655 KB  
Review
From Byproduct to Regulator: The Expanding Role of Lactate and Lactylation in Cardiovascular Physiology and Disease
by Hanqiang Deng
Biology 2026, 15(8), 642; https://doi.org/10.3390/biology15080642 - 18 Apr 2026
Viewed by 56
Abstract
Metabolic reprogramming plays a critical role in the pathogenesis of cardiovascular diseases. Historically regarded as a metabolic waste product, lactate has recently emerged as a critical regulator of vascular biology, exerting both metabolic and signaling functions. Moreover, the discovery of protein lactylation, a [...] Read more.
Metabolic reprogramming plays a critical role in the pathogenesis of cardiovascular diseases. Historically regarded as a metabolic waste product, lactate has recently emerged as a critical regulator of vascular biology, exerting both metabolic and signaling functions. Moreover, the discovery of protein lactylation, a novel post-translational modification derived from lactate, has revealed a direct link between metabolic flux and gene regulation. This review provides a comprehensive overview of the evolving roles of lactate and lactylation in cardiovascular physiology and disease, offering insights into potential therapeutic interventions. It first provides a historical perspective of lactate and lactylation, followed by an overview of lactate metabolism, lactate shuttle theory and signaling pathways. It then discusses the mechanism and regulation of lactylation, focusing on its writers, erasers, and readers. Finally, this review summarizes clinical implications of lactate and lactylation in various cardiovascular diseases, including atherosclerosis, pulmonary hypertension, myocardial infarction, heart failure, and diabetic vascular complications. A deeper understanding of the mechanisms underlying the lactate–lactylation axis may facilitate the development of new therapeutic strategies to prevent or treat cardiovascular diseases. Full article
Show Figures

Figure 1

22 pages, 1252 KB  
Article
A Holistic Nursing Surveillance Decision Support System for Postoperative Pulmonary Complications After Abdominal Surgery: A Retrospective Cohort Study
by Se Young Kim, Dong Hyun Lim, Dae Ho Kim and Ok Ran Jeong
Healthcare 2026, 14(8), 1083; https://doi.org/10.3390/healthcare14081083 - 18 Apr 2026
Viewed by 90
Abstract
Background/Objectives: Postoperative pulmonary complications (PPCs) following abdominal surgery are associated with prolonged hospitalization, delayed recovery, and increased mortality. Because nursing surveillance is essential for early detection and timely intervention, this study aimed to develop a holistic nursing surveillance decision support system integrating [...] Read more.
Background/Objectives: Postoperative pulmonary complications (PPCs) following abdominal surgery are associated with prolonged hospitalization, delayed recovery, and increased mortality. Because nursing surveillance is essential for early detection and timely intervention, this study aimed to develop a holistic nursing surveillance decision support system integrating PPC risk prediction with structured nursing action recommendations. Methods: In this retrospective cohort study, electronic medical record (EMR) data from approximately 6900 adult patients who underwent abdominal surgery at a single institution between January 2015 and September 2023 were analyzed. The study protocol was approved by the Institutional Review Board, and the requirement for informed consent was waived because of the retrospective study design. PPC risk was predicted using a tabular multilayer perceptron (MLP) encoder with SHapley Additive exPlanations (SHAP)-based feature weighting and a random forest classification head optimized via Optuna. Class imbalance was addressed using weighted sampling, class weighting in BCE(Binary Cross Entropy) With Logits Loss, and decision-threshold optimization. For clinical decision support, a large language model generated structured nursing surveillance recommendations in an action–evidence–rationale JSON format and was aligned through supervised fine-tuning (SFT) using human-evaluated cases. Results: The prediction model achieved an AUROC of 0.810, with an accuracy of 0.811, precision of 0.547, and recall of 0.545. In expert evaluation, the SFT-aligned model improved recommendation quality, reducing incorrect nursing actions from 19.3% to 8.0%. Conclusions: The proposed system demonstrates the feasibility of an end-to-end nursing surveillance decision support framework linking PPC risk prediction with structured clinical recommendations. The findings suggest its potential to support more accurate risk prediction and more actionable nursing surveillance for patients undergoing abdominal surgery. Full article
Show Figures

Figure 1

7 pages, 337 KB  
Case Report
When the Apex Deceives: A Mobile Left Ventricular Mass After Myocardial Infarction
by Georgios E. Zakynthinos, George Makavos, Nikolaos K. Kokkinos, Ourania Katsarou, Evangelos Oikonomou and Gerasimos Siasos
Reports 2026, 9(2), 124; https://doi.org/10.3390/reports9020124 - 18 Apr 2026
Viewed by 50
Abstract
Background and Clinical Significance: Mechanical complications and intracavitary thrombus are both recognized causes of clinical deterioration following acute myocardial infarction, yet they require fundamentally different therapeutic approaches. Distinguishing between these entities is critical, as misdiagnosis may lead to unnecessary surgical intervention or delayed [...] Read more.
Background and Clinical Significance: Mechanical complications and intracavitary thrombus are both recognized causes of clinical deterioration following acute myocardial infarction, yet they require fundamentally different therapeutic approaches. Distinguishing between these entities is critical, as misdiagnosis may lead to unnecessary surgical intervention or delayed anticoagulation with serious consequences. Left ventricular (LV) thrombus typically appears as a well-defined mass; however, atypical and highly mobile morphologies may closely mimic catastrophic post-infarction mechanical complications, creating significant diagnostic uncertainty. This case highlights the pivotal role of contrast-enhanced echocardiography in resolving such ambiguity and guiding appropriate management in a high-stakes clinical setting. Case Presentation: A 60-year-old man presented with acute dyspnea and pulmonary edema ten days after an anterior myocardial infarction treated with percutaneous coronary intervention, complicated by ischemic stroke. Transthoracic echocardiography demonstrated severe LV systolic dysfunction with moderate-to-severe mitral regurgitation and an unexpected, highly mobile, irregular mass protruding into the LV apex. The mass exhibited a shredded, tissue-like appearance, raising urgent concern for post-infarction mechanical complications, including papillary muscle rupture or apical myocardial disruption, and prompting immediate consideration of surgical intervention. Contrast-enhanced echocardiography was performed and revealed a mobile LV apical thrombus. Surgical management was avoided, and systemic anticoagulation was initiated, followed by transition to rivaroxaban in combination with ongoing dual antiplatelet therapy. The patient demonstrated rapid clinical improvement with optimized heart failure treatment and was discharged after four days, with planned follow-up imaging to assess thrombus resolution. Conclusions: Left ventricular thrombus may present with atypical, misleading morphologies that closely resemble life-threatening mechanical complications after myocardial infarction. Full article
(This article belongs to the Section Cardiology/Cardiovascular Medicine)
Show Figures

Figure 1

16 pages, 731 KB  
Systematic Review
Patient Satisfaction with Anticoagulation for Venous Thromboembolic Disease: A Systematic Review of Oral and Parenteral Regiments
by Eleftheria Elmina Lefkou, Anastasia Fragkaki, Maria Mirsini Miliori, Dimitra Latsou, Kalliopi Panagiotopoulou, Paraskevi Kotsi, Grigorios Gerotziafas and Maria Geitona
Medicina 2026, 62(4), 783; https://doi.org/10.3390/medicina62040783 - 17 Apr 2026
Viewed by 162
Abstract
Background and Objectives: Venous thromboembolic disease (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a major cause of morbidity and mortality worldwide and imposes a substantial financial burden on health systems due to both the direct and indirect costs [...] Read more.
Background and Objectives: Venous thromboembolic disease (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a major cause of morbidity and mortality worldwide and imposes a substantial financial burden on health systems due to both the direct and indirect costs of acute management and long-term complications. This systematic review aimed to assess patient satisfaction with anticoagulation therapy for VTE and to highlight potential differences according to the type of anticoagulant. The review focused on factors influencing the patient experience, such as perceived efficacy, ease of use, adverse effects, and health-related quality of life. Materials and Methods: A systematic review, without quantitative meta-analysis, was conducted in accordance with PRISMA 2020 guidelines. Articles were identified through searches in major databases (PubMed, Scopus, Cochrane Library and others) using keywords including “patient satisfaction”, “anticoagulation”, “venous thromboembolic disease”, and “quality of life”. In total, 21 studies published between 2009 and 2025 met the inclusion criteria. The studies assessed patient satisfaction with different types of anticoagulation, including vitamin K antagonists (VKAs), direct oral anticoagulants (DOACs), and low-molecular-weight heparin (LMWH) injections. Results: Across the included studies, patients generally reported higher levels of treatment satisfaction with DOACs compared with VKAs, mainly due to the absence of routine laboratory monitoring and fewer dietary restrictions. However, satisfaction varied according to age, sex, and clinical status. In specific patient populations, such as those with cancer-associated thrombosis, factors including fewer drug–drug interactions and perceptions of safety with LMWH appeared to influence treatment choice and satisfaction. Adverse effects, particularly bleeding, were identified as major drivers of dissatisfaction. Several studies suggested that higher treatment satisfaction was associated with better adherence, while quality of life appeared to improve in patients treated with DOACs in comparison with VKAs. Conclusions: Patient satisfaction is a critical component of successful VTE management. Overall, DOACs appear to be associated with higher treatment satisfaction than traditional therapies such as VKAs, although further high-quality research is needed to individualise anticoagulation strategies. Systematic incorporation of patient-reported satisfaction into clinical decision-making and into international guidelines may improve adherence, enhance quality of life, and ultimately increase the effectiveness of anticoagulation therapy. Full article
(This article belongs to the Special Issue Venous Thromboembolism: Diagnosis, Management, and Treatment)
Show Figures

Figure 1

11 pages, 1156 KB  
Case Report
Diffuse Alveolar Hemorrhage Complicating Influenza A Infection in an Immunocompetent Infant: A Case Report with Focused Pediatric Review
by Hai Thien Do, Hung Trong Dinh, Vuong Minh Tran, Lam Van Nguyen, Tung Viet Cao and Ngoc Nu Hoang Tran
J. Clin. Med. 2026, 15(8), 3062; https://doi.org/10.3390/jcm15083062 - 17 Apr 2026
Viewed by 106
Abstract
Background: Influenza is a common cause of hospitalization in young children, particularly infants. While most infections are self-limited, severe and life-threatening complications may occur. Diffuse alveolar hemorrhage (DAH) is a rare pulmonary manifestation of influenza, predominantly reported in adults, and is exceedingly [...] Read more.
Background: Influenza is a common cause of hospitalization in young children, particularly infants. While most infections are self-limited, severe and life-threatening complications may occur. Diffuse alveolar hemorrhage (DAH) is a rare pulmonary manifestation of influenza, predominantly reported in adults, and is exceedingly uncommon in immunocompetent infants. Case Presentation: We report the case of an 8-month-old previously healthy female infant who presented with influenza A infection and rapidly progressed to acute respiratory failure and shock despite antiviral therapy. Bleeding was noted from the nasal cavity prior to clinical deterioration, and during emergent endotracheal intubation, blood was observed flooding the bronchial tree, consistent with massive pulmonary hemorrhage. Flexible bronchoscopy showed diffusely erythematous and friable airway mucosa without an identifiable focal bleeding source, and early bronchoalveolar lavage was nondiagnostic. Nasopharyngeal testing confirmed influenza A (H3). Laboratory findings revealed severe systemic inflammation, leukopenia with neutropenia, and anemia with normal coagulation parameters. Chest imaging demonstrated bilateral pulmonary infiltrates. After exclusion of autoimmune, coagulation, immunodeficiency, and alternative infectious causes, a diagnosis of diffuse alveolar hemorrhage secondary to influenza A infection was established. The patient was successfully managed with supportive care, antiviral therapy, tranexamic acid, and empiric antibiotics, without corticosteroid treatment, and made a full recovery. Conclusions: This case emphasizes that influenza-associated DAH in infants may occur without overt hemoptysis and may not demonstrate classical BAL findings early in the disease course. Clinicians should maintain a high index of suspicion in rapidly deteriorating infants with influenza and diffuse pulmonary infiltrates. The optimal role of corticosteroids remains uncertain and should be individualized. Full article
(This article belongs to the Section Infectious Diseases)
Show Figures

Figure 1

13 pages, 1296 KB  
Article
Intraprocedural Findings and Outcomes of Redo Procedures After Voltage-Guided Ablation of Persistent Atrial Fibrillation
by Maxi Hartmann, Duc Nguyen, Violeta Mattea, Frank Steinborn, Mykhaylo Chapran, Ralph Surber, Kourosh Vathie, Mohamad Assani, Hussam Hamo, Hamzeh Alsous, Lisa C. Costello-Boerrigter, Jens Martin Kittner, Alexander Lauten, Christian Schulze and Anja Schade
J. Clin. Med. 2026, 15(8), 3005; https://doi.org/10.3390/jcm15083005 - 15 Apr 2026
Viewed by 193
Abstract
Background/Objectives: Pulmonary vein isolation (PVI) is the gold standard for atrial fibrillation (AF) ablation. Recently, a randomized study showed that adding voltage-guided ablation (VGA) in persistent AF cases was beneficial. The aim of the present study was to evaluate the safety, efficacy and [...] Read more.
Background/Objectives: Pulmonary vein isolation (PVI) is the gold standard for atrial fibrillation (AF) ablation. Recently, a randomized study showed that adding voltage-guided ablation (VGA) in persistent AF cases was beneficial. The aim of the present study was to evaluate the safety, efficacy and predictors of success of redo procedures after VGA in an exclusively persistent AF cohort. Methods: Data are derived from the prospective Erfurt AF ablation registry. Starting in 2015, ablation procedures were performed using CARTO3D and VGA. Patients receiving their first redo procedure between 01/2015 and 08/2022 were included. Follow-up included 72 h Holter ECG or device interrogation, ECG, symptom-triggered event recording, and questioning at 3 and 12 months after the redo procedure. The primary endpoint was freedom of recurrence of AF or atrial tachycardia (AT) without drugs between 3 and 12 months. Results: Altogether, 683 patients received a first VGA between January 2015 and May 2022, and 77 patients had their first redo procedure occurring 20 ± 17 months after the first procedure. During the first redo procedure, reconnected PVs were found in 44%, reconnected lines in 23% and new or progressive LVZs in 57% of patients. Complications occurred in two patients (2.6%). During follow-up one patient died, and one did not participate due to aphasia. It was found that 69% were free of recurrence and 61% were free of recurrence off drugs. Patients with recurrence were older than those without recurrence off drugs (73 ± 6 versus 69 ± 9 years, p = 0.049). Conclusions: Redo procedures after VGA in persistent AF have comparatively good results; although, many patients have progressive fibrosis. Full article
(This article belongs to the Section Cardiology)
Show Figures

Figure 1

14 pages, 1186 KB  
Article
Clinical Outcomes of Cardiac Implantable Electronic Device Infections in Octogenarians: A 20-Year Retrospective Cohort Study
by Sameer Al-Maisary, Migdat Mustafi, Gabriele Romano, Matthias Karck, Rawa Arif, Patricia Kraft and Mario Jesus Guzman-Ruvalcaba
J. Clin. Med. 2026, 15(8), 2996; https://doi.org/10.3390/jcm15082996 - 15 Apr 2026
Viewed by 166
Abstract
Background: The global demographic shift towards an aging population has driven a steady, exponential increase in the utilization of cardiac implantable electronic devices (CIEDs). Consequently, device-related infectious complications have emerged as a leading cause of morbidity and healthcare expenditure. Patients in their eighth [...] Read more.
Background: The global demographic shift towards an aging population has driven a steady, exponential increase in the utilization of cardiac implantable electronic devices (CIEDs). Consequently, device-related infectious complications have emerged as a leading cause of morbidity and healthcare expenditure. Patients in their eighth decade of life—octogenarians (aged 80–90 years)—represent an exceptionally high-risk demographic due to the compounding factors of physiological frailty, immunosenescence, and complex multi-morbidity. Despite this growing demographic, their specific clinical presentations, microbiological profiles, and procedural outcomes following infection remain poorly defined in the current literature. This study aimed to comprehensively compare the clinical characteristics, pathogen distribution, and in-hospital outcomes of CIED infections in an octogenarian cohort against a younger patient population. Methods: We conducted a robust retrospective cohort analysis of 383 consecutive patients treated for confirmed CIED infections at one major tertiary referral center (Heidelberg University Hospital) between January 2002 and December 2022. The cohort was stratified by age into octogenarians (n = 76) and a younger control group (n = 307). We systematically extracted and compared data regarding baseline clinical presentation, chronic comorbidities, detailed microbiological cultures (pocket, blood, and extracted leads), and definitive in-hospital outcomes, primarily mortality and length of stay. Results: The octogenarian cohort exhibited a significantly heavier comorbidity burden, notably higher rates of coronary artery disease (51.3% vs. 29.6%, p < 0.001), systemic hypertension (55.3% vs. 38.1%, p = 0.007), and chronic obstructive pulmonary disease (7.9% vs. 1.6%, p = 0.003). Furthermore, therapeutic systemic anticoagulant use was substantially more prevalent in the elderly group (60.5% vs. 45.0%, p = 0.015). Octogenarians presented overwhelmingly with localized generator pocket infections (73.0% vs. 30.0%, p < 0.001) but paradoxically also demonstrated higher rates of systemic bacteremia and sepsis (26.3% vs. 15.0%, p = 0.019). Microbiological analysis revealed a unique pathogen profile, with Staphylococcus capitis found with significantly higher frequency in the generator pockets of the elderly cohort. Remarkably, despite possessing a higher average lead burden (2.1 vs. 1.2 leads) and extreme comorbidity profiles, octogenarians demonstrated no statistically significant differences in in-hospital mortality (3.9% vs. 4.2%, p = 1.000) or overall length of hospital stay (14.7 vs. 17.2 days, p = 0.386) when compared to the younger cohort. Conclusions: Octogenarians suffering from CIED infections display highly distinct clinical and microbiological profiles, characterized predominantly by elevated rates of localized pocket infections, specific opportunistic pathogens, and a severe underlying comorbidity burden. Crucially, our findings indicate that with the application of modern extraction and management protocols, advanced age alone does not intrinsically correlate with increased in-hospital mortality. Future prevention and perioperative management strategies tailored to this rapidly expanding demographic must heavily prioritize the mitigation of pocket-related complications, particularly considering the high prevalence of concurrent anticoagulation therapy. Full article
(This article belongs to the Section Cardiovascular Medicine)
Show Figures

Figure 1

21 pages, 1058 KB  
Article
Cross-Disease Breathomics by PTR-TOF-MS: Multiclass Machine Learning and Network Remodeling across Asthma, COPD, Cystic Fibrosis, and Lymphangioleiomyomatosis
by Malika Mustafina, Artemiy Silantyev, Aleksandr Suvorov, Stanislav Krasovskiy, Marina Makarova, Alexander Chernyak, Olga Suvorova, Anna Shmidt, Daria Gognieva, Aleksandra Bykova, Nana Gogiberidze, Andrei Akselrod, Andrey Belevskiy, Sergey Avdeev, Vladimir Betelin, Abram Syrkin and Philipp Kopylov
Int. J. Mol. Sci. 2026, 27(8), 3483; https://doi.org/10.3390/ijms27083483 - 13 Apr 2026
Viewed by 283
Abstract
Chronic obstructive and inflammatory lung diseases share overlapping clinical manifestations and spirometric features, complicating differential diagnosis and monitoring. In this study, we performed an integrative real-time proton-transfer-reaction time-of-flight mass spectrometry (PTR-TOF-MS) breathomics analysis to assess whether exhaled volatile organic compound (VOC) profiles enable [...] Read more.
Chronic obstructive and inflammatory lung diseases share overlapping clinical manifestations and spirometric features, complicating differential diagnosis and monitoring. In this study, we performed an integrative real-time proton-transfer-reaction time-of-flight mass spectrometry (PTR-TOF-MS) breathomics analysis to assess whether exhaled volatile organic compound (VOC) profiles enable multiclass discrimination among bronchial asthma (BA), chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and lymphangioleiomyomatosis (LAM), with healthy individuals as controls. Breath VOC data from 843 subjects were analyzed using a stratified 70/30 train/test split. An ensemble feature selection strategy based on gradient boosting (XGBoost with SMOTE within cross-validation) identified stable VOC panels (top 25% selection probability), yielding 29 VOCs and 31 features including clinical covariates. On the independent test set, the VOC-only model achieved a macro-averaged one-vs-one (OvO) AUC of 0.866 (95% CI 0.829–0.903), while the combined model improved to 0.888 (95% CI 0.853–0.919), indicating modest value of clinical variables. Pairwise analysis demonstrated highest discrimination for CF (AUC up to 0.988), whereas BA and LAM showed lower sensitivity (<0.60), likely reflecting heterogeneity and limited sample size. Given differences in age, sex, BMI, and smoking status across cohorts, confounding effects were assessed, confirming that VOC signatures retain independent diagnostic information. Disease-specific VOC interaction networks revealed distinct remodeling patterns, with central metabolites not captured by univariate analysis. Overall, PTR-TOF-MS breathomics demonstrates proof-of-concept multiclass discrimination across chronic lung diseases. Full article
22 pages, 1970 KB  
Review
Post-COVID Respiratory Sequelae in COPD: Mucus Plugging, Infectious Complications, and Risk-Stratified Follow-Up
by Florina Cristiana Lucaciu, Norbert Wellmann, Ana Maria Mihai, Alexandra Sima, Ovidiu Rosca, Madalina-Ianca Suba, Andrada Tarau, Alexandra Bosoanca and Monica Marc
J. Clin. Med. 2026, 15(8), 2890; https://doi.org/10.3390/jcm15082890 - 10 Apr 2026
Viewed by 317
Abstract
Context/Objectives: In patients with COPD (chronic obstructive pulmonary disease), SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection represents an overlap of viral injury on a lung already affected by pathological mucus, altered mucociliary clearance, chronic inflammation, and impaired antiviral immunity. Methods: [...] Read more.
Context/Objectives: In patients with COPD (chronic obstructive pulmonary disease), SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection represents an overlap of viral injury on a lung already affected by pathological mucus, altered mucociliary clearance, chronic inflammation, and impaired antiviral immunity. Methods: A focused narrative review (2020–2025) was conducted using clinical, experimental, and consensus evidence. The evidence was synthesized qualitatively, with priority given to cohort studies, meta-analyses, and mechanism-focused studies with clinical relevance. Results: Mucus obstruction (“mucus plugs”) is frequent in COPD (41–67%) and is associated with unfavorable outcomes. COPD also increases the risk of post-COVID respiratory sequelae. Bacterial coinfection at presentation is uncommon (3–5%), whereas secondary bacterial infections are more frequent (14–18%), especially in severe disease requiring intensive care, where VA-LRTI/VAP (ventilator-associated lower respiratory tract infection/ventilator-associated pneumonia) become predominant. Sepsis, whether viral or mixed, reflects disease severity and may contribute to functional decline and susceptibility to reinfections; however, the concept of a post-acute “sepsis legacy” in COPD after COVID-19 should currently be regarded as a clinically plausible but still emerging hypothesis rather than an established COPD-specific outcome. During recovery, acute exacerbation risk rises to 5.6% versus 3.9%, peaking in the first 30 days after severe disease (aHR ≈ 8.14). Persistent dyspnea and reduced DLCO (diffusing capacity for carbon monoxide) suggest ARDS-related injury, tissue remodeling, and microvascular dysfunction. Conclusions: In COPD, post-COVID respiratory sequelae result from the interaction of mucus, immunity, and infectious/sepsis-related complications. The first post-discharge month is a critical period requiring careful risk stratification and targeted follow-up. Full article
(This article belongs to the Section Respiratory Medicine)
Show Figures

Figure 1

9 pages, 449 KB  
Case Report
Anaerobes in Late-Onset Prosthetic Joint Infection (PJI) and Colorectal Carcinoma
by Shi Ting Chiu, Mann Hong Tan, Seo Kiat Goh, Audrey Xinyun Han, Hee Nee Pang, Seng Jin Yeo, Sheng Xu and Eric Liu Xuan
J. Clin. Med. 2026, 15(8), 2870; https://doi.org/10.3390/jcm15082870 - 10 Apr 2026
Viewed by 238
Abstract
Background: Late-onset anaerobic prosthetic joint infection (PJI) is uncommon but may indicate underlying, previously asymptomatic colorectal malignancy. While the association between Streptococcus bovis group (SBG) bacteremia and colorectal cancer is well established, links between anaerobic PJIs and colorectal neoplasia are rarely reported. Anaerobic [...] Read more.
Background: Late-onset anaerobic prosthetic joint infection (PJI) is uncommon but may indicate underlying, previously asymptomatic colorectal malignancy. While the association between Streptococcus bovis group (SBG) bacteremia and colorectal cancer is well established, links between anaerobic PJIs and colorectal neoplasia are rarely reported. Anaerobic organisms originating from the gastrointestinal tract may translocate via the hematogenous route, and their presence in PJI should prompt clinicians to consider occult colorectal pathology. Methods: All periprosthetic arthroplasty infection cases between 2015 and 2025 were reviewed. Clinical records, diagnostic findings, microbiological data, and treatment outcomes were analyzed. Results: Three female patients (mean age 76.3 years) presented with late-onset PJI occurring at least five years after primary total knee arthroplasty. Causative organisms included Bacteroides fragilis, Morganella morganii, and Klebsiella pneumoniae. All patients underwent two single-stage revision surgeries and one debridement, antibiotics and implant retention (DAIR) procedure. Cross-sectional computed tomography imaging of the abdomen and pelvis (CT-AP) performed to evaluate hematogenous sources of infection consistently revealed previously undiagnosed colorectal malignancy. One patient had additional metastatic disease. Postoperative complications included one case of pulmonary embolism; no other major complications were observed. Conclusions: Anaerobic PJIs are rare, and their association with colorectal malignancy is not well established. These cases highlight the importance of evaluating potential gastrointestinal sources, including occult colorectal cancer, in patients presenting with late-onset anaerobic PJI. Full article
(This article belongs to the Section Orthopedics)
Show Figures

Figure 1

13 pages, 242 KB  
Article
Elevated Liver Enzymes Can Predict Complications Early After Pancreatic Resection
by Theresa Hofmann, Imad Kamaleddine, Clemens Schafmayer and Guido Alsfasser
J. Clin. Med. 2026, 15(8), 2851; https://doi.org/10.3390/jcm15082851 - 9 Apr 2026
Viewed by 246
Abstract
Background/Objectives: Pancreatic surgery has always been associated with a variety of complications. In the current study, we analyzed more than 800 consecutive pancreatic resections and tried to find clinically relevant routine parameters that could predict adverse outcomes at an early stage. We [...] Read more.
Background/Objectives: Pancreatic surgery has always been associated with a variety of complications. In the current study, we analyzed more than 800 consecutive pancreatic resections and tried to find clinically relevant routine parameters that could predict adverse outcomes at an early stage. We focused on hepato-pancreato-biliary routine parameters, especially on liver enzymes, because so far there are no studies showing any correlation between postoperatively elevated liver enzymes and postoperative complications. Methods: All pancreatic resections of a tertiary care center from 2003 until 2025 were documented prospectively and analyzed retrospectively. Data analysis comprised descriptive as well as inferential statistical analyses. Results: Laboratory values from 808 consecutive resections were analyzed for the first week after surgery. Elevated aspartate aminotransferase (AST) was associated with postoperative hemorrhage on POD 1, pulmonary insufficiency on POD 1 to 4, other complications on POD 1 to 5, MODS on POD 2 to 4, and development of pneumonia on POD 3 to 5. Elevated alanine aminotransferase (ALT) was associated with pulmonary insufficiency on POD 1 to 4 and POD 6, pneumonia, and other complications on POD 3. It was also associated with MODS on POD 1 to 6. Bilirubin elevated preoperatively and on POD 1 could not really predict any complication. In this study, we can also confirm that elevated amylase and lipase can predict complications. Conclusions: This is the first study that shows a correlation between postoperatively elevated AST and ALT and the development of postpancreatectomy complications. Elevated AST and ALT, especially in combination with postoperative pancreatitis or at least elevated pancreatic enzymes, can identify patients at risk for life-threatening conditions and might be useful to decrease failure-to-rescue patients. Full article
(This article belongs to the Special Issue Pancreatic Surgery: Clinical Practices and Challenges)
27 pages, 2786 KB  
Review
4-Hydroxynonenal, a Potential Biomarker for Lung Inflammatory Diseases
by Nancy Kaushal, Alexandria K. Vo, Nathan C. Kobus, Riddhi B. Dave and Kota V. Ramana
Int. J. Mol. Sci. 2026, 27(8), 3366; https://doi.org/10.3390/ijms27083366 - 9 Apr 2026
Viewed by 423
Abstract
Asthma, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS) are the major lung inflammatory complications affecting the global population. Exposure to allergens, infections, smoking, and environmental pollutants could cause persistent oxidative stress and dysregulated immune responses, leading to lung inflammatory [...] Read more.
Asthma, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS) are the major lung inflammatory complications affecting the global population. Exposure to allergens, infections, smoking, and environmental pollutants could cause persistent oxidative stress and dysregulated immune responses, leading to lung inflammatory complications. Increased oxidative stress can lead to lipid peroxidation and the formation of toxic lipid aldehydes. One of the major lipid aldehydes formed during lipid peroxidation is 4-hydroxy-2-nonenal (4-HNE). 4-HNE is well known to covalently modify proteins, nucleic acids, and lipids, thus modifying cellular signaling pathways and inflammatory cascades. Increased levels of 4-HNE have been identified in lung tissues, bronchoalveolar lavage (BAL) fluid, and the serum of patients with inflammatory lung conditions. Further, 4-HNE contributes to airway remodeling, mitochondrial dysfunction, and modulation of inflammatory responses in the lung epithelial cells. Recent studies also indicate the potential role of 4-HNE as an important mediator and a potential biomarker of various human disease progression, including the diagnosis and monitoring of lung inflammatory diseases. In this narrative review, we discuss current evidence on the pathological role of 4-HNE, its potential as a biomarker, and its importance for early detection and for potential therapeutic strategies in lung inflammatory complications. Full article
Show Figures

Figure 1

13 pages, 515 KB  
Article
Perioperative Outcomes of Neoadjuvant Immunochemotherapy for Locally Resectable Oesophageal Squamous Cell Carcinoma in Geriatric Patients Aged 70 Years or Older
by Qi Li, Song Lu, Yi Wang, Guangyuan Liu and Zhenjun Liu
Cancers 2026, 18(8), 1192; https://doi.org/10.3390/cancers18081192 - 8 Apr 2026
Viewed by 283
Abstract
Background: Neoadjuvant chemoradiotherapy (nCRT) followed by surgery has become the standard treatment for oesophageal cancer. However, data on the outcomes of neoadjuvant immunochemotherapy (nICT) in geriatric patients (≥70 years) who face higher perioperative risks are limited. Objective: This study aimed to compare the [...] Read more.
Background: Neoadjuvant chemoradiotherapy (nCRT) followed by surgery has become the standard treatment for oesophageal cancer. However, data on the outcomes of neoadjuvant immunochemotherapy (nICT) in geriatric patients (≥70 years) who face higher perioperative risks are limited. Objective: This study aimed to compare the perioperative outcomes of nICT versus nCRT in elderly patients with locally advanced oesophageal squamous cell carcinoma (ESCC). Method: This retrospective cohort study included 132 geriatric patients (median age: 72 years) treated with nICT (n = 51) or nCRT (n = 81) followed by esophagectomy at Sichuan Cancer Hospital (2021–2024). Intraoperative outcomes, postoperative pathologic stages, and complications, including pneumonia and anastomotic leakage, were assessed. Propensity score matching (PSM), overlap weighting (OW), and inverse probability of treatment weighting (IPTW) were used to adjust for baseline covariate imbalances in the sensitivity analysis. Results: Pathologic ypT0 stage tended to be higher in the nCRT group (p = 0.014), whereas ypN0 was higher in the nICT group (p = 0.035). No significant differences in intraoperative or postoperative outcomes between the two groups, except for pulmonary complications (p > 0.05). Compared with nCRT patients, nICT patients had significantly lower pulmonary complication rates (13.7% vs. 32.1%, p = 0.030), and multivariable analysis confirmed these findings (adjusted OR = 0.26; 95% CI: 0.08–0.85; p = 0.026). Sensitivity analyses showed consistent results. Conclusions: The safety of nICT is comparable to that of nCRT in geriatric ESCC patients, with significantly fewer pulmonary complications. These findings support nICT as a valuable alternative for elderly populations. Full article
(This article belongs to the Section Cancer Therapy)
Show Figures

Figure 1

Back to TopTop